Drugmaker from Japan relocating its N.J. workers to long-vacant site

Posted Aug 12, 2020

An oncology and neurology pharmaceutical company from Japan said Tuesday it would relocate all of its New Jersey employees to the former Hoffman-La Roche site on the border of Essex and Passaic counties.

Eisai Inc., of Tokyo, plans to transfer up to 1,200 of its research and development employees from Woodcliff Lake in Bergen County to the 116-acre site on the Nutley-Clifton border in late 2021, according to an announcement on the company’s website.

Hoffman-La Roche, the Swiss drugmaker best known for introducing benzodiazepines such as Valium, had employed 10,000 people at the campus before closing operations several years ago.

“This (site) will bring the Eisai community together in one place and drive a culture of new scientific horizons and entrepreneurial innovation,” Tatsuyuki Yasuno, president of Eisai Inc., said in a news release. “We draw inspiration from our patients and passion from our people. We break barriers every day. Our workplace will too.”

The site’s real-estate developers, Eugene Diaz and Edwin Cohen of Prism Capital Partners, said Eisai will lease all of 200 Metro Blvd. and be headquartered in the flagship office tower.

“Eisai brings exceptional scientific and business expertise to this ever-expanding center for New Jersey and global business in a lease that has brought the campus to 100% occupancy,” Cohen said in a statement.

The company said it will work closely on the site with the Hackensack Meridian Health Center for Discovery and Innovation, the Hackensack Meridian School of Medicine, Seton Hall University’s Graduate College of Nursing and School of Health and Medical Sciences, Quest Diagnostics, and others.

Do you like this post?

Be the first to comment